personally, I think this is an opportunity to accumulate the stock.
ACR have de-risked Axiron. WIll have $140m+ in the bank, with sales through 2011.
Don't forget Eli Lilly are a well oiled machine. Watch them run getting it to physicians.
While the product application is obviously very important, you can't discount the importance of the quality of the distributor.
ACR shareholders will enjoy a great 2011. There is $4 written all over this stock over the next 6 months with a special divi on top.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $6.116M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.5¢ | $1.574K | 104.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 609316 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 438346 | 3 |
View Market Depth
| Last trade - 11.39am 26/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |